Close

Immunometabolic hijacking of immune cells by a Pseudomonas aeruginosa quorum-sensing signal

Arunava Bandyopadhaya, Vijay K Singh, Arijit Chakraborty, A. Aria Tzika, Laurence G Rahme

Preprint posted on 3 October 2021 https://www.biorxiv.org/content/10.1101/2021.10.03.462785v1

Pseudomonas virulence factor 2-AA promotes glycolytic shift in macrophages that prevents inflammatory immune response.

Selected by Joao Mello-Vieira

Categories: cell biology, microbiology

Background

Bacterial virulence factors are important for the persistence of infection by changing the bacterium and the host cells. For example, Pseudomonas aeruginosa produce 2-aminoacetophenone (2-AA), a metabolite produced by the carbon metabolism of this bacterium, promotes chronic infection by preventing the activation of the immune cascade in the host.

In a paper published in 2016 in Nature Microbiolgy, Arunava Bandyopadhaya and colleagues reported that long exposures to 2-AA (over 24 hours) lead to immunosuppression of macrophages. They detailed the mechanism of this factor as increasing the expression of Histone Deacetylase 1 (HDAC1), while decreasing the activity of histone acetyltransferases. These changes effectively maintain the chromatin of macrophages in a “silent state”.

However, it is still unclear how 2-AA led to this epigenetic silencing. For this preprint, Bandyopadhaya and colleagues wanted to see if changes in the epigenetic landscape (caused by long term exposure to 2-AA) are a consequence of metabolic changes in the exposed cells.

 

Key Findings and Results

  • Mouse macrophages were exposed to 2-AA for 48 hours and later activated with 2-AA for another 24 hours (i.e., they were tolerized and then activated). These two treatments lead to the accumulation of pyruvate and lactate in the cytosol of the cell, with only a modest increase in acetyl-coA and ATP concentrations. Using a variety of enzyme and metabolite transporter inhibitors, the authors observed that this accumulation was due to a metabolic shift, away from oxidative phosphorylation to glycolysis.
  • Importantly, when naïve macrophages were exposed to 2-AA, they produced TNF alpha (an inflammatory cytokine). If cells had been tolerized to 2-AA and again exposed to 2-AA, their TNF alpha production was comparable to untreated and unstimulated macrophages. Yet, if tolerized macrophages were exposed to 2-AA in the presence of ATP, they were able to express TNF alpha as if they had not been tolerized. Conversely, if naïve cells were exposed to 2-AA in the presence of lactate, their TNF alpha production was hindered.
  • Finally, mice exposed to 2AA for 4 days and then infected with aeruginosa showed higher bacterial loads than infected, non-treated mice. Mice tolerized to 2AA also showed increased levels of lactate and decreased levels of acetyl-coA, validating the results obtained in vitro.

 

Significance

This manuscript shows very elegantly that 2-AA exposure leads to a metabolic shift, which results in the accumulation of lactate and limitation on ATP production that decreases the inflammatory potential of the exposed macrophage. These changes are caused by an increase in histone deacetylase activity, which in turn helps to metabolically reprogram macrophages into glycolysis. The practical consequence of this shift for P. aeruginosa is that the immune cells will respond poorly to 2-AA, delaying or blocking an effective immune response against the bacteria.

P. aeruginosa joins other bacteria (like Chlamydia pneumoniae, Legionella pneumophila, and Mycobacterium tuberculosis) that induce Warburg-like metabolic shifts in immune cells, enabling persistent infections. Other bacteria toxins (LPS and beta-glucan) can also affect Sirtuins, mammalian proteins that sense the nutritional status of the host cell, upregulating glycolysis. Yet, this is the first report of a bacterial protein directly leading to decreased levels of ERR-alpha and MPC-1 proteins, which are gatekeepers for the oxidative phosphorylation metabolism.

These findings highlight the sophisticated strategies pathogens have evolved to overcome the innate immune response. Because innate cells are short-lived (unlike T and B cells), information on how to fight bacteria is encoded by epigenetic changes, called trained immunity. By hijacking histone deacetylases, P. aeruginosa drives innate cells away from trained immunity, dampening the immune response.

The authors were able to reverse the effects of 2-AA in vitro by providing ATP to tolerized macrophages. Since 2-AA acts through epigenetic changes, they can be reversed using external stimuli. This provides an opportunity for the treatment of persistent P. aeruginosa infections and possibly other infectious diseases by using immunomodulation to overcome tolerance, favouring trained immunity.

Tags: glycolysis, immunity, innate immunity, metabolism, pseudomonas

Posted on: 14 October 2021

doi: https://doi.org/10.1242/prelights.30826

Read preprint (No Ratings Yet)

Author's response

Laurence G Rahme shared

JMV: Can these findings be extended to other virulence factors of P. aeruginosa, apart from 2-AA? For example, if 2-AA-tolerized cells are exposed to another virulence factor, do they also respond poorly? Or is this mechanism restricted to 2-AA?

LGR: 2-AA-tolerized cells indeed restrict P. aeruginosa virulence – Please see work work published in PLOS Pathogens (Bandyopadhaya et al. 2012).  We have not tried its effect against other pathogens but we plan to test it.

 

JMV: In your studies, you focused on mouse macrophages and on macrophage cell lines. Do you think your findings can be extended to other cells of the immune system, especially T and B cells? Is it possible that the metabolic shift caused by 2-AA leads to exhaustion of these cells?

LGR:  We are planning to address this question.

 

JMV: How do you think these findings will affect treatment options for P. aeruginosa? Do you think “metabolic-modulating” drugs (such as resveratrol, rapamycin or bezafibrate) should be given in combination with antibiotics for the treatment of persistent infections?

LGR: I’m not sure about resveratrol as 2-AA dampens the pro-inflammatory responses and  resveratrol has anti-inflammatory effect besides an anti-oxidant. Rapamycin will have the opposite than desire effects as it is an immunosuppressant. As for the bezafibrate – it might be worth testing.

Have your say

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign up to customise the site to your preferences and to receive alerts

Register here

preLists in the cell biology category:

‘In preprints’ from Development 2022-2023

A list of the preprints featured in Development's 'In preprints' articles between 2022-2023

 



List by Alex Eve, Katherine Brown

preLights peer support – preprints of interest

This is a preprint repository to organise the preprints and preLights covered through the 'preLights peer support' initiative.

 



List by preLights peer support

The Society for Developmental Biology 82nd Annual Meeting

This preList is made up of the preprints discussed during the Society for Developmental Biology 82nd Annual Meeting that took place in Chicago in July 2023.

 



List by Joyce Yu, Katherine Brown

CSHL 87th Symposium: Stem Cells

Preprints mentioned by speakers at the #CSHLsymp23

 



List by Alex Eve

Journal of Cell Science meeting ‘Imaging Cell Dynamics’

This preList highlights the preprints discussed at the JCS meeting 'Imaging Cell Dynamics'. The meeting was held from 14 - 17 May 2023 in Lisbon, Portugal and was organised by Erika Holzbaur, Jennifer Lippincott-Schwartz, Rob Parton and Michael Way.

 



List by Helen Zenner

9th International Symposium on the Biology of Vertebrate Sex Determination

This preList contains preprints discussed during the 9th International Symposium on the Biology of Vertebrate Sex Determination. This conference was held in Kona, Hawaii from April 17th to 21st 2023.

 



List by Martin Estermann

Alumni picks – preLights 5th Birthday

This preList contains preprints that were picked and highlighted by preLights Alumni - an initiative that was set up to mark preLights 5th birthday. More entries will follow throughout February and March 2023.

 



List by Sergio Menchero et al.

CellBio 2022 – An ASCB/EMBO Meeting

This preLists features preprints that were discussed and presented during the CellBio 2022 meeting in Washington, DC in December 2022.

 



List by Nadja Hümpfer et al.

Fibroblasts

The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!

 



List by Osvaldo Contreras

EMBL Synthetic Morphogenesis: From Gene Circuits to Tissue Architecture (2021)

A list of preprints mentioned at the #EESmorphoG virtual meeting in 2021.

 



List by Alex Eve

FENS 2020

A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020

 



List by Ana Dorrego-Rivas

Planar Cell Polarity – PCP

This preList contains preprints about the latest findings on Planar Cell Polarity (PCP) in various model organisms at the molecular, cellular and tissue levels.

 



List by Ana Dorrego-Rivas

BioMalPar XVI: Biology and Pathology of the Malaria Parasite

[under construction] Preprints presented at the (fully virtual) EMBL BioMalPar XVI, 17-18 May 2020 #emblmalaria

 



List by Dey Lab, Samantha Seah

1

Cell Polarity

Recent research from the field of cell polarity is summarized in this list of preprints. It comprises of studies focusing on various forms of cell polarity ranging from epithelial polarity, planar cell polarity to front-to-rear polarity.

 



List by Yamini Ravichandran

TAGC 2020

Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20

 



List by Maiko Kitaoka et al.

3D Gastruloids

A curated list of preprints related to Gastruloids (in vitro models of early development obtained by 3D aggregation of embryonic cells). Updated until July 2021.

 



List by Paul Gerald L. Sanchez and Stefano Vianello

ECFG15 – Fungal biology

Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome

 



List by Hiral Shah

ASCB EMBO Annual Meeting 2019

A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)

 



List by Madhuja Samaddar et al.

EMBL Seeing is Believing – Imaging the Molecular Processes of Life

Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019

 



List by Dey Lab

Autophagy

Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.

 



List by Sandra Malmgren Hill

Lung Disease and Regeneration

This preprint list compiles highlights from the field of lung biology.

 



List by Rob Hynds

Cellular metabolism

A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.

 



List by Pablo Ranea Robles

BSCB/BSDB Annual Meeting 2019

Preprints presented at the BSCB/BSDB Annual Meeting 2019

 



List by Dey Lab

MitoList

This list of preprints is focused on work expanding our knowledge on mitochondria in any organism, tissue or cell type, from the normal biology to the pathology.

 



List by Sandra Franco Iborra

Biophysical Society Annual Meeting 2019

Few of the preprints that were discussed in the recent BPS annual meeting at Baltimore, USA

 



List by Joseph Jose Thottacherry

ASCB/EMBO Annual Meeting 2018

This list relates to preprints that were discussed at the recent ASCB conference.

 



List by Dey Lab, Amanda Haage
Close